Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
Status:
Unknown status
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to evaluate the efficacy and safety of that test group
was administered with Mycophenolate Mofetil in combination with corticosteroid in patients
with advanced IgA nephropathy. The control group will be observed for up to 48 weeks without
administration of Mycophenolate Mofetil.
Phase:
Phase 4
Details
Lead Sponsor:
Yonsei University
Collaborators:
Chonbuk National University Hospital Chong Kun Dang Pharmaceutical Corp. Inje University Kyung Hee University Hospital at Gangdong Kyungpook National University Kyungpook National University Hospital Pusan National University Yangsan Hospital Seoul St. Mary's Hospital